Antiretroviral-based microbicides and oral pre-exposure prophylaxis for HIV prevention. (August 2011)

• Record Type: Journal Article
• Authors: Ramjee, Gita
• Is Part Of: Future virology. Volume 6:Number 8(2011)
• Page Start: 997
• Page End: 1014
• Publication Date: 2011-08
• Subjects: emtricitabine -- HIV prevention -- microbicide -- pre-exposure prophylaxis -- tenofovir -- topical gel; Virology -- Periodicals; Virus diseases -- Treatment -- Periodicals; 616.9101
• DOI: 10.2217/fvl.11.64
• Languages: English
• ISSNs: 1746-0794

Abstract

Numerous HIV prevention options have been tested, with limited success. Microbicides have been the focus of research specifically targeted to prevent new infections among women. After decades of research using non-HIV-specific microbicides, we now have proof of concept for antiretroviral-based microbicides. Issues of drug resistance, frequency of HIV testing and adherence to treatment remain to be explored. Drugs used for HIV treatment and with good safety profiles have been shown to provide protection to men who have sex with men. Ethical issues surrounding cost, access, future design of HIV prevention trials and composition of the prevention package offered to trial participants remain. The role of advocacy and market research will be crucial to ensure effective interventions are accessed and supported. There is renewed hope in the HIV prevention field with collective efforts needed to ensure we get the new prevention tools and options into the hands of men and women at risk of HIV infection. The purpose of this paper is to provide a review of existing research and identify issues for future enquiry.